Form 8-K

8-K — Ambiq Micro, Inc.

Accession: 0001193125-26-343443

Filed: 2026-08-11

Period: 2026-08-11

CIK: 0001500412

SIC: 3674 (SEMICONDUCTORS & RELATED DEVICES)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — ambq-20260811.htm (Primary)

EX-99.1 (ambq-ex99_1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: ambq-20260811.htm · Sequence: 1

8-K

0001500412false00015004122026-08-112026-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 11, 2026

Ambiq Micro, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware

001-42766

27-1911389

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

6500 River Place Blvd.

Building 7

Austin, Texas

78730

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 512 879-2850

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, $0.000001 par value per share

AMBQ

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 11, 2026, Ambiq Micro, Inc. (the "Company") issued a press release to report financial results for its second quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 and is incorporated by reference herein.

The information set forth in this Item 2.02, including Exhibit 99.1 hereto, shall be deemed "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit Number

Description

99.1

Press Release of Ambiq Micro, Inc. dated August 11, 2026

104

Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Ambiq Micro, Inc.

Date:

August 11, 2026

By:

/s/ Jeffrey G. Winzeler

Name:

Title:

Jeffrey G. Winzeler

Chief Financial Officer

EX-99.1

Filename: ambq-ex99_1.htm · Sequence: 2

EX-99.1

Ambiq Reports Second Quarter 2026 Financial Results

Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions

Gross profit more than doubled year-over-year on higher net sales and margin expansion

Expect third quarter net sales of $36.0 million to $37.0 million, which would represent the sixth consecutive quarter of sequential growth

AUSTIN, Texas, August 11, 2026 — Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the second quarter 2026.

Second Quarter 2026 and Recent Highlights

•

Delivered strong net sales on growing edge AI demand momentum: Net sales increased approximately 90%, year-over-year, driven by accelerating edge AI demand across customers, end markets and products.

•

Gross profit outpaced net sales growth: GAAP gross profit increased approximately 113% and non-GAAP gross profit increased approximately 109% year-over-year, with GAAP gross margin and non-GAAP gross margin expanding by 490 basis points and 450 basis points respectively.

•

Enhanced financial flexibility to capitalize on growth opportunities ahead: Completed an upsized public offering in June, raising approximately $168 million in net proceeds.

•

Expanded edge AI software stack: Launched heliaCORE and compressionKIT to accelerate customers' deployment of small footprint and energy efficient AI models on the Apollo SoC families. We also announced heliaPROFILER, a new open-source profiling tool that speeds customers' AI model development.

•

Strengthened global capital markets access: Announced a dual listing on the Singapore Exchange Main Board under ticker AMQ, expanding investor reach across Asia and reinforcing our long-term growth strategy in the global semiconductor market.

Management Commentary

“Since the start of the year, we have seen a step-change in demand, further reinforcing our belief in the scale and durability of the edge AI opportunity. That momentum drove our net sales up approximately 90% year over year, marking our fifth consecutive quarter of growth, and we expect demand to strengthen even further in the second half of the year,” said Fumihide Esaka, CEO of Ambiq. “Given the rapid acceleration in AI demand, we and the broader semiconductor industry are facing supply constraints. Even with this, we are on pace to more than double net sales in the second half of 2026 compared to last year. We are acting decisively to expand capacity, support our customers and capture the full opportunity we see to enable the next generation of intelligent edge products."

Summary of Second Quarter 2026 Results

GAAP

(Unaudited; $ in thousands)

Three months ended June 30,

Three months ended March 31,

Three months ended June 30,

Quarter over quarter change

Year over year change

2026

2025

Net sales

33,901

25,060

17,873

35.3

89.7

Gross profit

15,267

10,891

7,170

40.2

112.9

Gross margin

45.0

43.5

40.1

1.5 pts

4.9 pts

Operating expense

23,994

22,580

15,967

6.3

50.3

Net loss

(7,115

)

(10,171

)

(8,496

)

3,056

1,381

NON-GAAP FINANCIAL MEASURES*

(Unaudited; $ in thousands)

Three months ended June 30,

Three months ended March 31,

Three months ended June 30,

Quarter over quarter change

Year over year change

2026

2025

Non-GAAP Gross profit

15,989

11,577

7,640

38.1

109.3

Non-GAAP Gross margin

47.2

46.2

42.7

1.0 pts

4.5 pts

Non-GAAP Operating expense

19,374

18,144

13,819

6.8

40.2

Non-GAAP Net loss

(1,772

)

(5,046

)

(5,862

)

3,274

4,090

*Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expense and non-GAAP net loss are non-GAAP financial measures. See "Non-GAAP Financial Measures" below for definitions of each of these measures, and the tables accompanying this press release for reconciliations of these measures to their most comparable GAAP measure.

Third Quarter Business Outlook1

Ambiq’s current expectations for the quarter ending September 30, 2026, include the following:

•

Net sales within a range of $36.0 million to $37.0 million, reflecting accelerating demand for edge AI, partially constrained by industry-wide supply availability

•

Non-GAAP gross margin between 46.5% and 47.5%, driven by favorable mix and manufacturing efficiencies

•

Non-GAAP operating expense of $24.0 million to $25.0 million, reflecting investments to support product development and our strategic growth priorities, including planned intellectual property investments

•

Non-GAAP net loss per share within a range of ($0.20) to ($0.12) based on a weighted average share count of 24.17 million shares outstanding

1Ambiq's financial outlook is based on assumptions that it believes to be reasonable as of the date of this release, but may be materially affected by many factors, as discussed below in "Forward-Looking Statements." Actual results may vary from the guidance and the variations may be material. We undertake no intent or obligation to publicly update or revise this outlook, whether as a result of new information, future events or otherwise, except as required by law. The Company is unable to include a reconciliation of forward-looking non-GAAP net loss per share, non-GAAP gross margin and non-GAAP operating expense to the most directly comparable GAAP measure without unreasonable effort due to the high variability with respect to the impact of items such as depreciation and amortization and, stock-based compensation expense and other items that are excluded from these non-GAAP measures.

Conference Call

Ambiq will host a conference call for analysts and investors today at 8:30 a.m. Eastern Time. Interested participants can access the call by dialing 1-833-461-5787 and providing conference ID 195766563. International callers may join the call by dialing +1-585-542-9983, using the same code. The call will also be available as a live and archived webcast on the Events & Presentations section of Ambiq's Investor Relations website.

About Ambiq Micro

Ambiq’s mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Built on its patented Subthreshold Power Optimized Technology (SPOT®) and the HELIA™ AI platform, Ambiq empowers manufacturers to bring more capable AI to the edge, where power, memory, and energy efficiency are most critical. Ambiq enables more intelligent, always-on edge devices across healthcare, wearables, industrial automation, smart environments, and other emerging AI applications. With more than 300 million devices shipped worldwide, Ambiq continues to shape the future of always-on Edge AI. Headquartered in Austin, Texas, Ambiq serves customers globally. For more information, visit www.ambiq.com.

Non-GAAP Financial Measures

Ambiq supplements its reporting of financial information determined under generally accepted accounting principles in the United States of America (GAAP), including the use of non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP R&D expenses, non-GAAP SG&A expenses and non-GAAP net loss. These non-GAAP financial measures help management make strategic decisions, establish budgets and operational goals for managing the business, analyzing financial results, and evaluating business performance. Ambiq defines non-GAAP gross profit as gross profit adjusted to exclude expenses not directly attributable to gross profit, such as depreciation and amortization, stock-based compensation and gain on nonmonetary transactions. Ambiq defines non-GAAP gross margin as non-GAAP gross profit as a percentage of net sales.  Ambiq defines non-GAAP operating expenses, non-GAAP R&D expenses and

non-GAAP SG&A expenses as operating expenses, R&D expenses and SG&A expenses, as applicable, adjusted to exclude expenses not directly attributable to operating expenses, R&D expenses and SG&A expenses, as applicable, such as depreciation and amortization, stock-based compensation, severance costs, and IPO and other transaction costs, as applicable. Ambiq defines non-GAAP net loss as net loss adjusted to exclude expenses not directly attributable to the performance of operations, such as income taxes, depreciation and amortization, stock-based compensation, gain on nonmonetary transactions, severance costs, IPO and other transaction costs and warrant valuation.

Ambiq believes these non-GAAP financial measures provide additional tools for investors to use in comparing core business and results of operations over multiple periods with other companies in the industry, many of which present similar non-GAAP financial measures. However, Ambiq's presentation of non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP R&D expenses, non-GAAP SG&A expenses, and non-GAAP net loss may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. These non-GAAP measures have limitations, and should not be considered as the sole measures of our performance and should not be considered in isolation from, or as a substitute for, the most comparable measure calculated in accordance with GAAP.

Forward-Looking Statements

The statements contained in this press release that are not historical facts are forward-looking statements. You can identify forward-looking statements because they contain words such as "believes," "expects," "may," "will," "should," "seeks," "intends," "plans," "estimates," or "anticipates," or similar expressions which concern our strategy, plans, projections or intentions. These forward-looking statements may be included throughout this press release, and include, but are not limited to, statements relating to Ambiq's expectations around its strategic initiatives, growth trajectory and expected third quarter business outlook. By their nature, forward-looking statements are not statements of historical fact or guarantees of future performance and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify including those described in the section titled "Risk Factors" in Ambiq's Annual Report on 10-K for the year ended December 31, 2025, as well as in other filings Ambiq may make with the SEC in the future. Ambiq's expectations, beliefs and projections are expressed in good faith and Ambiq believes there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this release. Ambiq undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

Availability of Information on Our Website

We routinely use our investor relations website (ir.ambiq.com) to post presentations to investors and other important information, including information that may be material. Accordingly, we encourage investors and others interested in Ambiq to review the information it makes public on its investor relations website.

AMBIQ MICRO, INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in thousands, except share and per share amounts)

June 30,

December 31,

2026

2025

Assets

Current assets:

Cash and cash equivalents

366,774

140,275

Accounts receivable, net

17,528

7,286

Inventories

29,365

16,937

Prepaid expenses and other current assets

2,958

3,421

Total current assets

416,625

167,919

Property, equipment and software, net of accumulated depreciation and

amortization of $15,480 and $14,632, respectively

4,328

4,137

Right-of-use assets, net

3,244

638

Intangible assets, net of accumulated amortization of $13,469 and $10,752,

respectively

10,224

11,593

Other assets

1,201

393

Total assets

435,622

184,680

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

10,615

8,577

Accrued and other current liabilities

14,469

10,201

Short-term lease liabilities

1,034

400

Total current liabilities

26,118

19,178

Long-term lease liabilities

3,549

278

Other long-term liabilities

1,283

2,765

Total liabilities

30,950

22,221

Commitments and contingencies (Note 5)

Stockholders’ equity:

Common stock, $0.000001 par value; 500,000,000 shares authorized; 24,146,260 shares and 18,316,928 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

—

Additional paid-in capital

778,920

519,610

Accumulated deficit

(373,997

)

(356,711

)

Accumulated other comprehensive loss

(251

)

(440

)

Total stockholders’ equity

404,672

162,459

Total liabilities and stockholders’ equity

435,622

184,680

AMBIQ MICRO, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

(in thousands, except share and per share amounts)

Three months ended

Six months ended

June 30, 2026

June 30, 2025

June 30, 2026

June 30, 2025

Net sales

33,901

17,873

58,961

33,605

Cost of sales

18,634

10,703

32,803

18,046

Gross profit

15,267

7,170

26,158

15,559

Operating expenses:

Research and development

14,139

8,898

26,971

17,585

Selling, general and administrative

9,855

7,069

19,603

15,512

Total operating expenses

23,994

15,967

46,574

33,097

Loss from operations

(8,727

)

(8,797

)

(20,416

)

(17,538

)

Other income, net

1,613

315

3,134

776

Loss before income taxes

(7,114

)

(8,482

)

(17,282

)

(16,762

)

Provision for income taxes

Net loss

(7,115

)

(8,496

)

(17,286

)

(16,780

)

Net loss per share, basic and diluted

(0.32

)

(18.89

)

(0.82

)

(37.59

)

Weighted-average shares used in computing net loss per share, basic and diluted

21,742,929

449,785

21,073,361

446,390

Comprehensive loss:

Currency translation adjustment

124

110

189

Comprehensive loss

(6,991

)

(8,386

)

(17,097

)

(16,700

)

AMBIQ MICRO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

For the six months ended June 30,

2026

2025

Cash flows from operating activities

Net loss

(17,286

)

(16,780

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

3,525

3,814

Stock-based compensation

6,919

1,616

Gain on receipt of nonmonetary tangible assets

—

(1,600

)

Change in right-of-use assets

386

510

Change in warrant valuations and cancellations

—

Other

—

(110

)

Changes in operating assets and liabilities

Accounts receivable

(10,242

)

2,705

Inventories

(12,428

)

(751

)

Prepaid expenses and other assets

931

(1,257

)

Other long-term assets

)

Accounts payable

4,002

874

Accrued and other current liabilities

3,872

446

Other long-term liabilities

(406

)

(75

)

Net cash used in operating activities

(20,678

)

(10,549

)

Cash flows from investing activities

Purchase of intangible assets

(5,120

)

(2,687

)

Purchases of property, equipment and software

(781

)

(454

)

Net cash used in investing activities

(5,901

)

(3,141

)

Cash flows from financing activities

Proceeds from issuance of common stock in connection with follow-on offerings, net of underwriting discounts and commissions

245,468

—

Payment of deferred offering costs

(1,542

)

—

Proceeds from exercise of stock options

6,099

175

Proceeds from exercise of warrants

3,010

—

Net cash provided by financing activities

253,035

175

Effect of exchange rate changes on cash and cash equivalents

Net increase (decrease) in cash and cash equivalents

226,499

(13,476

)

Cash and cash equivalents at beginning of period

140,275

60,981

Cash and cash equivalents at end of period

366,774

47,505

Supplemental disclosure of non-cash investing and financing activities

Intangible assets in accounts payable, accrued and other long-term liabilities

5,991

8,328

Gain on receipt of nonmonetary tangible assets

—

1,600

Right-of-use assets obtained in exchange for new operating lease liabilities

3,018

383

The following table reconcile the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.

Non-GAAP Net Loss:

Three months ended June 30,

Six months ended June 30,

Three months ended March 31,

2026

2025

2026

2025

2026

(in thousands)

Net loss

(7,115

)

(8,496

)

(17,286

)

(16,780

)

(10,171

)

Add:

Income taxes

Depreciation and amortization

1,785

1,853

3,525

3,814

1,740

Stock-based compensation

3,557

765

6,919

1,616

3,362

Gain on nonmonetary transaction

—

(1,600

)

—

Severance costs

—

IPO and other transaction costs

—

1,793

—

Warrant valuation

—

Non-GAAP net loss

(1,772

)

(5,862

)

(6,818

)

(11,079

)

(5,046

)

Non-GAAP Gross Profit and Non-GAAP Gross Margin:

Three months ended June 30,

Six months ended June 30,

Three months ended March 31,

2026

2025

2026

2025

2026

(in thousands)

Gross profit

15,267

7,170

26,158

15,559

10,891

Add:

Depreciation and amortization

504

430

1,003

992

499

Stock-based compensation

218

405

100

187

Gain on nonmonetary transaction

—

(1,600

)

—

Non-GAAP gross profit

15,989

7,640

27,566

15,051

11,577

Non-GAAP Operating Expenses:

Three months ended June 30,

Six months ended June 30,

Three months ended March 31,

2026

2025

2026

2025

2026

(in thousands)

Operating expenses

23,994

15,967

46,574

33,097

22,580

Less:

Depreciation and amortization

1,281

1,423

2,522

2,822

1,241

Stock-based compensation

3,339

725

6,514

1,516

3,175

Severance

—

IPO and other transaction costs

—

1,793

—

Non-GAAP operating expenses

19,374

13,819

37,518

26,966

18,144

Three months ended June 30,

Six months ended June 30,

Three months ended March 31,

Research and development

2026

2025

2026

2025

2026

(in thousands)

Operating expenses

14,139

8,898

26,971

17,585

12,832

Less:

Depreciation and amortization

1,244

1,389

2,446

2,646

1,202

Stock-based compensation

1,731

328

3,249

717

1,518

Severance

—

Non-GAAP research and development expenses

11,164

7,181

21,256

14,222

10,092

Three months ended June 30,

Six months ended June 30,

Three months ended March 31,

Selling, general, and administrative

2026

2025

2026

2025

2026

(in thousands)

Operating expenses

9,855

7,069

19,603

15,512

9,748

Less:

Depreciation and amortization

175

Stock-based compensation

1,608

397

3,265

798

1,657

IPO and other transaction costs

—

1,793

—

Non-GAAP selling, general, and administrative expenses

8,210

6,639

16,262

12,746

8,052

Non-GAAP Net Loss per Share:

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

(in thousands, except share and per share amounts)

GAAP net loss

(7,115

)

(8,496

)

(17,286

)

(16,780

)

Weighted-average shares used in computing GAAP net loss per share

21,742,929

449,785

21,073,361

446,390

GAAP net loss per share

(0.32

)

(18.89

)

(0.82

)

(37.59

)

Non-GAAP net loss

(1,772

)

(5,862

)

(6,818

)

(11,079

)

Weighted-average shares used in computing non-GAAP net loss per share

21,742,929

449,785

21,073,361

446,390

Non-GAAP net loss per share

(0.07

)

(13.03

)

(0.32

)

(24.82

)

Company Contact

Charlene Wan

VP of Corporate Marketing

cwan@ambiq.com

Investor Relations Contact

Teneo

Christina Coronios

christina.coronios@teneo.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 5

v3.26.1

Document And Entity Information

Aug. 11, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 11, 2026

Entity Registrant Name

Ambiq Micro, Inc.

Entity Central Index Key

0001500412

Entity Emerging Growth Company

true

Entity File Number

001-42766

Entity Incorporation, State or Country Code

Entity Tax Identification Number

27-1911389

Entity Address, Address Line One

6500 River Place Blvd.

Entity Address, Address Line Two

Building 7

Entity Address, City or Town

Austin

Entity Address, State or Province

Entity Address, Postal Zip Code

78730

City Area Code

512

Local Phone Number

879-2850

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Ex Transition Period

false

Title of 12(b) Security

Common Stock, $0.000001 par value per share

Trading Symbol

AMBQ

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration